These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 28423592)
1. Protective effect of hydrogen sulphide against myocardial hypertrophy in mice. Shao M; Zhuo C; Jiang R; Chen G; Shan J; Ping J; Tian H; Wang L; Lin C; Hu L Oncotarget; 2017 Apr; 8(14):22344-22352. PubMed ID: 28423592 [TBL] [Abstract][Full Text] [Related]
2. Antioxidant effects of hydrogen sulfide on left ventricular remodeling in smoking rats are mediated via PI3K/Akt-dependent activation of Nrf2. Zhou X; Zhao L; Mao J; Huang J; Chen J Toxicol Sci; 2015 Mar; 144(1):197-203. PubMed ID: 25516494 [TBL] [Abstract][Full Text] [Related]
3. Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats. Xu J; Li H; Irwin MG; Xia ZY; Mao X; Lei S; Wong GT; Hung V; Cheung CW; Fang X; Clanachan AS; Xia Z Crit Care Med; 2014 Aug; 42(8):e583-94. PubMed ID: 24810525 [TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway. Nie P; Meng F; Zhang J; Wei X; Shen C Oxid Med Cell Longev; 2019; 2019():4625912. PubMed ID: 31285785 [TBL] [Abstract][Full Text] [Related]
5. Nitrite Therapy Ameliorates Myocardial Dysfunction via H2S and Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2)-Dependent Signaling in Chronic Heart Failure. Donnarumma E; Bhushan S; Bradley JM; Otsuka H; Donnelly EL; Lefer DJ; Islam KN J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473036 [TBL] [Abstract][Full Text] [Related]
6. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway. Zhao M; Guo H; Chen J; Fujino M; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Wang J; Huang H; Zheng S; Hei M; Li J; Huang S; Li J; Ma X; Chen Y; Zhao L; Zhuang J; Zhu P; Li XK Am J Physiol Cell Physiol; 2015 Apr; 308(8):C665-72. PubMed ID: 25652453 [TBL] [Abstract][Full Text] [Related]
8. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907 [TBL] [Abstract][Full Text] [Related]
9. Hydrogen Sulfide Improves Myocardial Remodeling via Downregulated Angiotensin Ⅱ/AT1R Pathway in Renovascular Hypertensive Rats. Liu SY; Duan XC; Jin S; Teng X; Xiao L; Xue HM; Wu YM Am J Hypertens; 2017 Jan; 30(1):67-74. PubMed ID: 27600580 [TBL] [Abstract][Full Text] [Related]
10. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation. Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348 [TBL] [Abstract][Full Text] [Related]
11. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis. Tang C; Yin G; Huang C; Wang H; Gao J; Luo J; Zhang Z; Wang J; Hong J; Chai X Biomed Pharmacother; 2020 Sep; 129():110357. PubMed ID: 32531679 [TBL] [Abstract][Full Text] [Related]
12. Carnosol prevents cardiac remodeling and ventricular arrhythmias in pressure overload-induced heart failure mice. Fang Z; Lu M; Huang R; Wang G; Yushanjiang F; Jiang X; Li J Phytother Res; 2024 Jul; 38(7):3763-3781. PubMed ID: 38831669 [TBL] [Abstract][Full Text] [Related]
13. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway. Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089 [TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner. Meng G; Liu J; Liu S; Song Q; Liu L; Xie L; Han Y; Ji Y Br J Pharmacol; 2018 Apr; 175(8):1126-1145. PubMed ID: 28503736 [TBL] [Abstract][Full Text] [Related]
16. Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway. Chen X; Wan W; Guo Y; Ye T; Fo Y; Sun Y; Qu C; Yang B; Zhang C Mol Med; 2021 Sep; 27(1):100. PubMed ID: 34488618 [TBL] [Abstract][Full Text] [Related]
17. Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway. Liu C; Wu QQ; Cai ZL; Xie SY; Duan MX; Xie QW; Yuan Y; Deng W; Tang QZ J Cell Mol Med; 2019 Sep; 23(9):6466-6478. PubMed ID: 31293067 [TBL] [Abstract][Full Text] [Related]
18. Nrf2 protects against maladaptive cardiac responses to hemodynamic stress. Li J; Ichikawa T; Villacorta L; Janicki JS; Brower GL; Yamamoto M; Cui T Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1843-50. PubMed ID: 19592468 [TBL] [Abstract][Full Text] [Related]
19. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway. Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333 [TBL] [Abstract][Full Text] [Related]